Incorporating Fecal Calprotectin in Clinical Practice for Patients with Moderate to Severely Active Ulcerative Colitis Treated with Biologics or Small Molecule Inhibitors

BACKGROUND: We applied the GRADE (Grading of Recommendations Assessment, Development and Evaluation) framework to evaluate the performance of fecal calprotectin (FC) as an alternative to endoscopy in patients with moderate-severe ulcerative colitis (UC) treated with a biologic agent or tofacitinib....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Gastroenterol
Autori principali: Dulai, Parambir S., Battat, Robert, Barsky, Maria, Nguyen, Nghia H., Ma, Christopher, Narula, Neeraj, Mosli, Mahmoud, Casteele, Niels Vande, Boland, Brigid S., Prokop, Larry, Murad, M. Hassan, D’Haens, Geert, Feagan, Brian G., Sandborn, William J., Jairath, Vipul, Singh, Siddharth
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274901/
https://ncbi.nlm.nih.gov/pubmed/32384283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ajg.0000000000000596
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi